Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

2.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

3.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

4.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

5.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

6.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

7.

Risk of treatment-related esophageal cancer among breast cancer survivors.

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF Jr, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM.

Ann Oncol. 2012 Dec;23(12):3081-91. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.

8.

Second malignant neoplasms in digestive organs after childhood cancer: a cohort-nested case-control study.

Tukenova M, Diallo I, Anderson H, Hawkins M, Garwicz S, Sankila R, El Fayech C, Winter D, Rubino C, Adjadj E, Haddy N, Oberlin O, Moller T, Langmark F, Tryggvadottir L, Pacquement H, Svahn-Tapper G, de Vathaire F.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e383-90. doi: 10.1016/j.ijrobp.2011.05.069.

PMID:
22284034
9.

Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries.

Garwicz S, Anderson H, Olsen JH, Winther JF, Sankila R, Langmark F, Tryggvadóttir L, Möller TR; Association of the Nordic Cancer Registries; Nordic Society for Pediatric Hematology Oncology.

Int J Cancer. 2012 Oct 1;131(7):1659-66. doi: 10.1002/ijc.27393. Epub 2012 Jan 11.

10.

Effect of screening mammography on breast-cancer mortality in Norway.

Kalager M, Zelen M, Langmark F, Adami HO.

N Engl J Med. 2010 Sep 23;363(13):1203-10. doi: 10.1056/NEJMoa1000727.

11.

Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer.

Brackmann S, Aamodt G, Andersen SN, Roald B, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.

Inflamm Bowel Dis. 2010 Mar;16(3):474-81. doi: 10.1002/ibd.21053.

PMID:
19714748
12.

Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.

Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S.

J Natl Cancer Inst. 2009 Jun 3;101(11):806-13. doi: 10.1093/jnci/djp104. Epub 2009 May 26.

PMID:
19470947
13.

Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.

Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA.

J Clin Oncol. 2009 Feb 20;27(6):967-73. doi: 10.1200/JCO.2008.18.4549. Epub 2008 Dec 29.

14.

Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness.

Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B.

Eur J Cancer. 2009 May;45(7):1218-1231. doi: 10.1016/j.ejca.2008.10.037. Epub 2008 Dec 16.

PMID:
19091545
15.

[Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?].

Aasbrenn M, Langmark F, Wisløff F.

Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2712-4. Norwegian.

16.

Two distinct groups of colorectal cancer in inflammatory bowel disease.

Brackmann S, Andersen SN, Aamodt G, Roald B, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.

Inflamm Bowel Dis. 2009 Jan;15(1):9-16. doi: 10.1002/ibd.20542.

PMID:
18618636
17.

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.

Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.

Scand J Gastroenterol. 2009;44(1):46-55. doi: 10.1080/00365520801977568.

PMID:
18609187
18.

Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients.

Howard R, Gilbert E, Lynch CF, Hall P, Storm H, Holowaty E, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Allan JM, Travis LB.

Ann Epidemiol. 2008 May;18(5):416-21. doi: 10.1016/j.annepidem.2008.01.003.

19.

[Lung cancer without metastases--are all patients with resectable tumor operated?].

Rostad H, Strand TE, Langmark FY, Naalsund A.

Tidsskr Nor Laegeforen. 2008 Apr 17;128(8):920-3. Norwegian.

20.

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.

Helsing P, Nymoen DA, Ariansen S, Steine SJ, Maehle L, Aamdal S, Langmark F, Loeb M, Akslen LA, Molven A, Andresen PA.

Genes Chromosomes Cancer. 2008 Feb;47(2):175-84.

PMID:
18023021
21.

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB.

J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. Epub 2007 Oct 30.

PMID:
17971527
22.

Time trends in the incidence of acute lymphoblastic leukemia among children 1976-2002: a population-based Nordic study.

Svendsen AL, Feychting M, Klaeboe L, Langmark F, Schüz J.

J Pediatr. 2007 Nov;151(5):548-50.

PMID:
17961705
23.

Long-term risk of cancer in membranous nephropathy patients.

Bjørneklett R, Vikse BE, Svarstad E, Aasarød K, Bostad L, Langmark F, Iversen BM.

Am J Kidney Dis. 2007 Sep;50(3):396-403.

PMID:
17720518
24.
25.

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB.

J Clin Oncol. 2007 Apr 20;25(12):1489-97. Epub 2007 Mar 19.

PMID:
17372278
26.

Risk of second non-hematological malignancies among 376,825 breast cancer survivors.

Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fosså SD, Travis LB.

Breast Cancer Res Treat. 2007 Dec;106(3):439-51. Epub 2007 Feb 3.

PMID:
17277968
27.

Leukemia following breast cancer: an international population-based study of 376,825 women.

Howard RA, Gilbert ES, Chen BE, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Travis LB.

Breast Cancer Res Treat. 2007 Nov;105(3):359-68. Epub 2007 Jan 13.

PMID:
17221155
28.

[Incidence of breast cancer before and after implementation of mammography screening].

Hofvind S, Sørum R, Haldorsen T, Langmark F.

Tidsskr Nor Laegeforen. 2006 Nov 16;126(22):2935-8. Norwegian.

29.

Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.

Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, De Vathaire F, Olsen JH, Døllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Sankila R, Tulinius H, Möller T.

Acta Oncol. 2006;45(4):438-48.

PMID:
16760180
30.

Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia.

Svensson E, Møller B, Tretli S, Barlow L, Engholm G, Pukkala E, Rahu M, Tryggvadóttir L, Langmark F, Grotmol T.

Cancer Causes Control. 2005 Apr;16(3):215-23.

PMID:
15947873
31.

Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report.

Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R.

J Natl Cancer Inst Monogr. 2005;(34):77-82.

PMID:
15784830
32.

[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma].

Fosså SD, Holte H, Holmen MM, Bjøro T, Langmark F, Hess SL, Kvaløy S.

Tidsskr Nor Laegeforen. 2005 Jan 6;125(1):41-4. Norwegian.

33.

[Overdiagnosis and mammography screening].

Langmark F, Thoresen S.

Tidsskr Nor Laegeforen. 2004 Nov 4;124(21):2800; author reply 2800. Norwegian. No abstract available.

34.

Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999.

Johannesen TB, Angell-Andersen E, Tretli S, Langmark F, Lote K.

Neuroepidemiology. 2004 May-Jun;23(3):101-9.

PMID:
15084778
35.

Public Awareness and Lobbying: Group 3 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003.

Hoff G, Blanchard J, Crespi M, Wood LF, Keighley M, Lamy V, Langmark F, Peterson K, Rey JF, Robertshaw K, Zakaria S.

Endoscopy. 2004 Apr;36(4):359-61. No abstract available.

PMID:
15057691
36.

Colorectal cancer survival trends in Norway 1958-1997.

Angell-Andersen E, Tretli S, Coleman MP, Langmark F, Grotmol T.

Eur J Cancer. 2004 Mar;40(5):734-42.

PMID:
15010075
37.

European health systems and cancer care.

Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm HH, Forman D, Quinn M, Aareleid T, Sankila R, Hakulinen T, Faivre J, Ziegler H, Tryggvadòttir L, Zanetti R, Dalmas M, Visser O, Langmark F, Bielska-Lasota M, Wronkowski Z, Pinheiro PS, Brewster DH, Plesko I, Pompe-Kirn V, Martinez-Garcia C, Barlow L, Möller T, Lutz JM, André M, Steward JA.

Ann Oncol. 2003;14 Suppl 5:v41-60.

PMID:
14684500
38.

Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends.

Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov'a M, Storm HH, Aareleid T, Hakulinen T, Velten M, Lef'evre H, Danzon A, Buemi A, Daur'es JP, Ménégoz F, Raverdy N, Sauvage M, Ziegler H, Comber H, Paci E, Vercelli M, De Lisi V, Tumino R, Zanetti R, Berrino F, Stanta G, Langmark F, Rachtan J, Mezyk R, Blaszczyk J, Ivan P, Primic-Zakelj M, Martínez AC, Izarzugaza I, Borràs J, Garcia CM, Garau I, Sánchez NC, Aicua A, Barlow L, Torhorst J, Bouchardy C, Levi F, Fisch T, Probst N, Visser O, Quinn M, Gavin A, Brewster D, Mikov M; ENCR Working Group.

Cancer Causes Control. 2003 Oct;14(8):791-803. Erratum in: Cancer Causes Control. 2004 Feb;15(1):103.

PMID:
14674744
40.

Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study.

Johannesen TB, Langmark F, Lote K.

Eur J Cancer. 2003 Nov;39(16):2355-63.

PMID:
14556928
41.

Relative survival of patients with prostate cancer as a first or subsequent tumor--a Nordic collaborative study.

Heinävaara S, Sankila R, Storm H, Langmark F, Hakulinen T.

Cancer Causes Control. 2002 Nov;13(9):797-806.

PMID:
12462544
42.

Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis.

Svensson E, Grotmol T, Hoff G, Langmark F, Norstein J, Tretli S.

Eur J Cancer Prev. 2002 Oct;11(5):489-95.

PMID:
12394247
43.

A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.

Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Søreide O; Norwegian Rectal Cancer Group.

Dis Colon Rectum. 2002 Jul;45(7):857-66.

PMID:
12130870
44.

[Cancer in siblings of children with cancer].

Winther JF, Sankila R, Boice JD Jr, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Möller T, Mulvihill JJ, Olafsdottir GH, Ritvanen A, Olsen JH.

Ugeskr Laeger. 2002 Jun 3;164(23):3073-9. Danish.

PMID:
12082866
45.

[Does organized mammographic screening reduce breast cancer mortality? The Cancer Registry's view on the current debate].

Wang H, Hofvind S, Tretli S, Thoresen S, Langmark F.

Tidsskr Nor Laegeforen. 2002 Jan 20;122(2):211-3. Norwegian. No abstract available.

PMID:
11873583
46.

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study.

Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Möller TR, Mulvihill JJ, Olafsdottir GH, Ritvanen A, Olsen JH.

Lancet. 2001 Sep 1;358(9283):711-7.

PMID:
11551577
47.

[Psychological, social and economic situation of women surgically treated for cancer].

Kåresen R, Langmark F.

Tidsskr Nor Laegeforen. 2000 Sep 30;120(23):2741-8. Norwegian.

48.
49.

[Diagnostic delay in malignant melanoma].

Faye RS, Helsing P, Langmark F.

Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1023-5. Norwegian.

50.

Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I.

Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH.

Scand J Gastroenterol. 1999 Apr;34(4):414-20.

PMID:
10365903

Supplemental Content

Loading ...
Support Center